PUBLISHER: The Insight Partners | PRODUCT CODE: 1463677
PUBLISHER: The Insight Partners | PRODUCT CODE: 1463677
The South & Central America DNA extraction, isolation, and purification market was valued at US$ 101.16 million in 2022 and is expected to reach US$ 193.64 million by 2030; it is estimated to grow at a CAGR of 8.5% from 2022 to 2030.
New Product Launches and Approvals Fuels the South & Central America DNA Extraction, Isolation, and Purification Market
The biotechnology industry is developing significantly due to the increasing demand for technologically advanced products. This, in turn, results in a rise in the number of new product developments, launches, and approvals. Additionally, major market players engage in R&D activities to ensure the innovation and development of efficient products. A few of the recent product launches and developments in the DNA extraction, isolation, and purification market are mentioned below.
CD Bioparticles is a leading manufacturer and supplier of various products in application areas such as in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. In August 2023, the company announced the launch of its new line of DNA extraction and purification kits made for the quick and accurate isolation of DNA, including cell-free DNA (cfDNA), genomic DNA, plasmid DNA, tissue DNA, mitochondrial DNA, and PCR In March 2023, BioEcho Life Sciences announced the launch of EchoLUTION FFPE DNA Kit that offers an innovative way to extract DNA from Formalin-Fixed Paraffin-Embedded (FFPE) samples. In April 2022, Purigen Biosystems, Inc., one of the leading providers of next-generation technologies, announced the launch of Ionic Cells to Pure DNA Kit. The kit has been optimized to allow the users of Ionic Purification Systems to extract higher-quality DNA from white blood cells (WBCs), peripheral blood mononuclear cells (PBMCs), and cultured or sorted cells.
Thus, an increase in product developments, and launches is likely to create ample opportunities for the growth of the DNA extraction, isolation, and purification market in the coming years.
South & Central America DNA Extraction, Isolation, and Purification Market Overview
The increasing prevalence of genetic diseases leads to clinical urgency for adopting rapid diagnostic options such as DNA kits, reagents, and instruments. In addition, the benefits of DNA products for rapid analysis and high-precision test results, and their use in a wide range of applications are among the major factors responsible for the increased adoption of DNA analysis in South & Central America. In Argentina, the growing demand for advanced diagnostic equipment in genetics, oncology, and cytogenetics has propelled the adoption of DNA products. According to the WHO, Argentina recorded ~130,878 new cancer cases in 2020. Rising cancer cases propel the demand for DNA extraction as this genetic material is instrumental in the early detection of genetic anomalies and in designing personalized treatment strategies. Thus, the increasing geriatric population, coupled with the burgeoning prevalence of cancer, highlights the importance of precise genetic analysis, which fuels the growth of the DNA extraction, isolation, and purification market in South & Central America.
South & Central America DNA Extraction, Isolation, and Purification Market Revenue and Forecast to 2030 (US$ Million)
South & Central America DNA Extraction, Isolation, and Purification Market Segmentation
The South & Central America DNA extraction, isolation, and purification market is segmented based on type, method, sample type, source, application, end user, and country.
Based on type, the South & Central America DNA extraction, isolation, and purification market is categorized into kits, instrument, and reagent. The kits segment held the largest South & Central America DNA extraction, isolation, and purification market share in 2022.
In terms of method, the South & Central America DNA extraction, isolation, and purification market is bifurcated into chemical method and physical method. The chemical method segment held a larger South & Central America DNA extraction, isolation, and purification market share in 2022. The chemical method is further subsegmented into phenol chloroform, silica gel, proteinase, and others. The physical method is further subsegmented into magnetic bead and paper.
By sample type, the South & Central America DNA extraction, isolation, and purification market is segmented into blood, body fluid, and others. The blood segment held the largest South & Central America DNA extraction, isolation, and purification market share in 2022.
By source, the South & Central America DNA extraction, isolation, and purification market is segmented into genomic and microbial. The genomic segment held a larger South & Central America DNA extraction, isolation, and purification market share in 2022. The microbial segment is further subsegmented into bacteria and virus.
Based on application, the South & Central America DNA extraction, isolation, and purification market is categorized into PCR test, next generation sequencing, micro array, and others. The next generation sequencing segment held the largest South & Central America DNA extraction, isolation, and purification market share in 2022. The PCR test segment is further subsegmented into qPCR, multiplex PCR, 16S PCR, and others.
By end user, the South & Central America DNA extraction, isolation, and purification market is segmented into diagnostic center and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The diagnostic center and research laboratories segment held the largest South & Central America DNA extraction, isolation, and purification market share in 2022.
Based on country, the South & Central America DNA extraction, isolation, and purification market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America DNA extraction, isolation, and purification market in 2022.
Bio-Rad Laboratories Inc, Danaher Corp, GE HealthCare Technologies Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Merck KGaA, Illumina Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America DNA extraction, isolation, and purification market.
Table of Content